| Session Introduction | |||||
|
Tue4 Oct11:05am(5 mins)
|
|
Chris Herring |
|
Claire Dobson | |
|
Room: Auditorium 3
|
|||||
| TCR Evolution, revolution: How Adaptimmune is developing innovative TCR T-cell therapies to treat solid tumors | |||||
|
Tue4 Oct11:10am(30 mins)
|
|
Dr Jo Brewer | |||
|
Room: Auditorium 3
|
|||||
| The journey from discovery to therapy begins with a single cell | |||||
|
Tue4 Oct11:40am(30 mins)
|
|
Stephen Hague | |||
|
Room: Auditorium 3
|
|||||
| From Stem-Cells to T-Cells: Next-Generation DNA NanoVectors -an Alternative Non-Integrating DNA Vector Platform for Regenerative Medicine and Immunotherapy | |||||
|
Tue4 Oct12:10pm(30 mins)
|
|
Dr Richard Harbottle | |||
|
Room: Auditorium 3
|
|||||
| Automating high-throughput NGS and qPCR assays: Meet the Biomark™ X and the Juno™ | |||||
|
Tue4 Oct12:40pm(5 mins)
|
|
James Curtis | |||
|
Room: Auditorium 3
|
|||||
| Pin-point™ – A Modular Base Editing System Driving Cell and Gene therapies | |||||
|
Tue4 Oct02:00pm(30 mins)
|
|
Dr Michael Anbar | |||
|
Room: Auditorium 3
|
|||||
| Assist Plus Pipetting Platform | |||||
|
Tue4 Oct02:30pm(5 mins)
|
|
Ms Sharon Barnard | |||
|
Room: Auditorium 3
|
|||||
| Bioluminescent assay tools for TCR-T and CAR-T development and characterisation | |||||
|
Tue4 Oct02:35pm(5 mins)
|
|
Dr Craig Malcolm | |||
|
Room: Auditorium 3
|
|||||
| Armouring CAR-T cells therapy against the immunosuppressive microenvironment in solid tumour | |||||
|
Tue4 Oct02:40pm(30 mins)
|
|
Dr Romain Lara | |||
|
Room: Auditorium 3
|
|||||
| Unlocking a revolutionary class of in vivo reprogramming therapies through systematic, unbiased identification of the key cell switches controlling cell fate | |||||
|
Tue4 Oct03:45pm(30 mins)
|
|
Dr Louise Modis | |||
|
Room: Auditorium 3
|
|||||
| The impact of not understanding the genetic landscape, Ignorance will cost you time and money. | |||||
|
Tue4 Oct04:15pm(15 mins)
|
|
Melanie Maerken | |||
|
Room: Auditorium 3
|
|||||
| Next Generation Platforms for Human Gene Therapy | |||||
|
Tue4 Oct04:30pm(30 mins)
|
|
Prof Aravind Asokan | |||
|
Room: Auditorium 3
|
|||||
| Session Introduction | |||||
|
Wed5 Oct11:00am(5 mins)
|
|
Mario Richter |
|
Kirsten Tschapalda | |
|
Room: Auditorium 3
|
|||||
| Efficient low-priced custom automation at Abbvie | |||||
|
Wed5 Oct11:05am(30 mins)
|
|
Mario Richter | |||
|
Room: Auditorium 3
|
|||||
| Automated analysis workflow to identify metal contamination in HTS outputs | |||||
|
Wed5 Oct11:35am(30 mins)
|
|
Dr Rachel Moore | |||
|
Room: Auditorium 3
|
|||||
| iPSC automation platform | |||||
|
Wed5 Oct12:05pm(30 mins)
|
|
Dr Martine Geraerts | |||
|
Room: Auditorium 3
|
|||||
| Multiparametric drug discovery facilitated by automated liquid handling | |||||
|
Wed5 Oct12:35pm(15 mins)
|
|
Mark Graham | |||
|
Room: Auditorium 3
|
|||||
| Collaborative AMR Implementation in Biopharmaceutical Labs | |||||
|
Wed5 Oct02:00pm(30 mins)
|
|
Mr Thomas Albanetti | |||
|
Room: Auditorium 3
|
|||||
| HTS Assay detection at its best! - New PHERAstar FSX features improve data quality and sample processing | |||||
|
Wed5 Oct02:30pm(5 mins)
|
|
Catherine Wark | |||
|
Room: Auditorium 3
|
|||||
| Cost Effective Decapping | |||||
|
Wed5 Oct02:35pm(5 mins)
|
|
Mr Adam McGinnis | |||
|
Room: Auditorium 3
|
|||||
| An Educational Approach for Drug Discover Using AI Driven Closed Loop Experimentation | |||||
|
Wed5 Oct02:40pm(30 mins)
|
|
Dr Joshua Kangas | |||
|
Room: Auditorium 3
|
|||||
| Enhancing the lead discovery assay value chain by an orchestrated lab automation ecosystem | |||||
|
Wed5 Oct03:45pm(30 mins)
|
|
Kirsten Tschapalda |
|
Dr Federica Morandi | |
|
Room: Auditorium 3
|
|||||
| High Throughput Affinity Screening for Rapid Hit Discovery and Prosecuting Challenging Targets | |||||
|
Wed5 Oct04:15pm(30 mins)
|
|
Miss Poppy Llowarch | |||
|
Room: Auditorium 3
|
|||||
